Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Romi Ghose

Showing results (31-40 of 33) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 33 results.
The Annals of Pharmacotherapy|January 5, 2019
Neratinib in HER2-Positive Breast Cancer PatientsRutugandha Paranjpe, Dima Basatneh, Gabriel Tao, et al.
Current Cancer Drug Targets|September 12, 2019
Xiao-Chai-Hu-Tang (XCHT) Intervening Irinotecan's Disposition: The Potential of XCHT in Alleviating Irinotecan-Induced DiarrheaRongjin Sun, Sumit Basu, Min Zeng, et al.
Toxicology and Applied Pharmacology|May 11, 2020
Irinotecan-mediated diarrhea is mainly correlated with intestinal exposure to SN-38: Critical role of gut UgtRongjin Sun, Lijun Zhu, Li Li, et al.
Pageof 4

Showing results (31-40 of 33) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 33 results.
The Annals of Pharmacotherapy|January 5, 2019
Neratinib in HER2-Positive Breast Cancer PatientsRutugandha Paranjpe, Dima Basatneh, Gabriel Tao, et al.
Current Cancer Drug Targets|September 12, 2019
Xiao-Chai-Hu-Tang (XCHT) Intervening Irinotecan's Disposition: The Potential of XCHT in Alleviating Irinotecan-Induced DiarrheaRongjin Sun, Sumit Basu, Min Zeng, et al.
Toxicology and Applied Pharmacology|May 11, 2020
Irinotecan-mediated diarrhea is mainly correlated with intestinal exposure to SN-38: Critical role of gut UgtRongjin Sun, Lijun Zhu, Li Li, et al.
Pageof 4